Bausch & Lomb BLCO
NYSE BLCO
$17.56 -0.23 (-1.29%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bausch & Lomb (BLCO) Short term Debt (2022 - 2026)

Bausch & Lomb's (BLCO) quarterly Short term Debt came in at $43.0 million in Q2 2026, up 975.0% on a YoY basis from $4.0 million in Q2 2025, and up 10.26% quarter-over-quarter from $39.0 million in Q1 2026.

Analysis

Bausch & Lomb (BLCO) Short term Debt (2022 - 2026) Analysis & Trends

Bausch & Lomb (BLCO) has reported Short term Debt for 5 consecutive years, with $43.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Short term Debt rose 975.0% year-over-year to $43.0 million; the trailing twelve-month figure through Jun 2026 stood at $43.0 million (up 975.0% YoY), and the FY2025 full-year result was $39.0 million, down 2.5% from the prior year.
  • Short term Debt grew to $43.0 million in Q2 2026 per BLCO's latest filing, from $39.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $43.0 million in Q2 2026 and bottomed at $4.0 million in Q3 2022.
  • Historically, Short term Debt has averaged $17.7 million across 5 years, with a median of $5.5 million in 2024.
  • The sharpest annual moves came in 2025 and 2026: Short term Debt retreated 2.5% in 2025, then surged 975.0% in 2026.
  • Over 5 years, Short term Debt stood at $25.0 million in 2022, then advanced by 20.0% to $30.0 million in 2023, then soared by 33.33% to $40.0 million in 2024, then slipped by 2.5% to $39.0 million in 2025, then climbed by 10.26% to $43.0 million in 2026.
  • According to Business Quant data, Short term Debt over the past three periods registered $43.0 million, $39.0 million, and $39.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn
10 Bausch & Lomb 6.28 Bn 5.90 Bn 867.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.00 Mn
Mar 31, 2026 39.00 Mn
Dec 31, 2025 39.00 Mn
Sep 30, 2025 28.00 Mn
Jun 30, 2025 4.00 Mn
Mar 31, 2025 6.00 Mn
Dec 31, 2024 40.00 Mn
Sep 30, 2024 4.00 Mn
Jun 30, 2024 4.00 Mn
Mar 31, 2024 5.00 Mn
Dec 31, 2023 30.00 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 4.00 Mn
Mar 31, 2023 4.00 Mn
Dec 31, 2022 25.00 Mn
Sep 30, 2022 4.00 Mn